Market Cap 195.70M
Revenue (ttm) 0.00
Net Income (ttm) -156.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.74
Volume 661,900
Avg Vol 1,061,064
Day's Range N/A - N/A
Shares Out 58.59M
Stochastic %K 77%
Beta 2.20
Analysts Sell
Price Target $36.00

Latest News on OMER

Omeros Corporation Reports First Quarter 2025 Financial Results

May 15, 2025, 4:05 PM EDT - 21 days ago

Omeros Corporation Reports First Quarter 2025 Financial Results


Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight

Apr 11, 2025, 3:06 PM EDT - 7 weeks ago

Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight


Omeros Corporation (OMER) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 8:57 PM EDT - 2 months ago

Omeros Corporation (OMER) Q4 2024 Earnings Call Transcript


Omeros Corporation (OMER) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 10:22 PM EST - 7 months ago

Omeros Corporation (OMER) Q3 2024 Earnings Call Transcript


Omeros Corporation Reports Third Quarter 2024 Financial Results

Nov 13, 2024, 4:02 PM EST - 7 months ago

Omeros Corporation Reports Third Quarter 2024 Financial Results


Omeros Corporation (OMER) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 1:05 AM EDT - 10 months ago

Omeros Corporation (OMER) Q2 2024 Earnings Call Transcript


Omeros Corporation Reports Second Quarter 2024 Financial Results

Aug 7, 2024, 4:02 PM EDT - 10 months ago

Omeros Corporation Reports Second Quarter 2024 Financial Results


Omeros Corporation (OMER) Q1 2024 Earnings Call Transcript

May 15, 2024, 7:23 PM EDT - 1 year ago

Omeros Corporation (OMER) Q1 2024 Earnings Call Transcript


Omeros Corporation (OMER) Q4 2023 Earnings Call Transcript

Apr 1, 2024, 8:09 PM EDT - 1 year ago

Omeros Corporation (OMER) Q4 2023 Earnings Call Transcript


Omeros: Why It Is Worthwhile To Bet On Narsoplimab

Nov 27, 2023, 1:18 AM EST - 1 year ago

Omeros: Why It Is Worthwhile To Bet On Narsoplimab


Omeros Corporation (OMER) Q3 2023 Earnings Call Transcript

Nov 10, 2023, 10:32 AM EST - 1 year ago

Omeros Corporation (OMER) Q3 2023 Earnings Call Transcript